Market Trends of Clinical Trial Logistics Industry
Increasing Specimen Collection From Homes
The evolution of the pharmaceutical industry has led to changes in the nature of clinical trials. The focus is now on evidence-based medicine, patient-centered care, and the development of orphan drugs and personalized cell and gene therapies. This shift has driven the growth of direct-to-patient sample delivery and collection services.
Clinical trials are no longer limited to investigator sites but are now conducted in patients' homes, where they receive treatment and have blood samples taken for shipping. This approach requires drug delivery and sample collection services to be provided at the patient's doorstep.
To meet these demands, sponsor firms are outsourcing clinical trial activities to specialized providers to improve efficiency and reduce costs.
The increasing prevalence of chronic diseases, an aging population, and the emergence of Asian countries as key players in home healthcare are expected to drive further market expansion.
Asia-Pacific is experiencing significant growth
Asia-Pacific, particularly East and South Asia, is experiencing significant growth due to increasing healthcare needs and government funding for research. The demand for medications is rising due to the growing elderly population, which is also driving the clinical trial logistics market in the region. Major pharmaceutical companies are outsourcing their drug development services to countries like India, Malaysia, China, and Singapore, further fueling this market growth.
Patients are now comparing home care services to those offered by other industries like entertainment, banking, and retail.
While samples for pathological tests can be collected at home, physical visits to testing centers are still preferred for X-rays and ultrasounds. Although the trend of home sample collection is welcomed, service providers need to be adaptable to meet customer needs.
